01:18 PM, 26th Jul 2023
Aspira Pathlab & Diagnostics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2023 inter alia to consider and approve the Unaudited Financial Results of the Company for the Quarter ended 30th June 2023 and to consider any other business with the permission of the Chair.